Projects funded by the NCN
Novel peptide inhibitors of dipeptidyl peptidase IV (DPP IV) as novel approach for diabetes type 2 and inflammatory bowel diseases treatment
2013/11/N/NZ7/02354
Keywords:
diabetes type 2 inflammatory bowel diseases dipeptidyl peptidase IV inhibitor anti-diabetic drug anti-inflammatory drug
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 6 - announced on 2013-09-16
Amount awarded: 135 187 PLN
Project start date (Y-m-d): 2014-09-22
Project end date (Y-m-d): 2018-09-21
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled